DOCSLIB.ORG

List of Predicted Circfam120a Target Mrnas Gene in Pathway Species Gene Name

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
List of Predicted Circfam120a Target Mrnas Gene in Pathway Species Gene Name List of predicted circFAM120A target mRNAs Gene in pathway Species Gene name HRAS Homo sapiens HRas proto-oncogene, GTPase (HRAS) ADCY1 Homo sapiens Adenylate cyclase 1 (ADCY1) ADCY2 Homo sapiens Adenylate cyclase 2 (ADCY2) ADCY7 Homo sapiens Adenylate cyclase 7 (ADCY7) PTGS2 Homo sapiens Prostaglandin-endoperoxide synthase 2 (PTGS2) PGF Homo sapiens Placental growth factor (PGF) ADCY5 Homo sapiens Adenylate cyclase 5 (ADCY5) STAT5A Homo sapiens Signal transducer and activator of transcription 5A (STAT5A) ADCY6 Homo sapiens Adenylate cyclase 6 (ADCY6) STAT5B Homo sapiens Signal transducer and activator of transcription 5B (STAT5B) LPAR3 Homo sapiens Lysophosphatidic acid receptor 3 (LPAR3) LPAR2 Homo sapiens Lysophosphatidic acid receptor 2 (LPAR2) CTNNB1 Homo sapiens Catenin beta 1 (CTNNB1) CUL2 Homo sapiens Cullin 2 (CUL2) RARA Homo sapiens Retinoic acid receptor alpha (RARA) GNG2 Homo sapiens G protein subunit gamma 2 (GNG2) RARB Homo sapiens Retinoic acid receptor beta (RARB) GNG3 Homo sapiens G protein subunit gamma 3 (GNG3) FAS Homo sapiens Fas cell surface death receptor (FAS) GNG4 Homo sapiens G protein subunit gamma 4 (GNG4) GNG7 Homo sapiens G protein subunit gamma 7 (GNG7) PIK3CG Homo sapiens Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma (PIK3CG) WNT10B Homo sapiens Wnt family member 10B (WNT10B) BCR Homo sapiens BCR, RhoGEF and GTPase activating protein (BCR) BRAF Homo sapiens B-Raf proto-oncogene, serine/threonine kinase (BRAF) RXRB Homo sapiens Retinoid X receptor beta (RXRB) ROCK2 Homo sapiens Rho associated coiled-coil containing protein kinase 2 (ROCK2) pik3cb Homo sapiens Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta (PIK3CB) RXRA Homo sapiens Retinoid X receptor alpha (RXRA) PIK3CD Homo sapiens Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta (PIK3CD) SKP2 Homo sapiens S-phase kinase associated protein 2 (SKP2) CTNNA1 Homo sapiens Catenin alpha 1 (CTNNA1) CTNNA3 Homo sapiens Catenin alpha 3 (CTNNA3) VEGFB Homo sapiens Vascular endothelial growth factor B (VEGFB) JUP Homo sapiens Junction plakoglobin (JUP) MAPK1 Homo sapiens Mitogen-activated protein kinase 1 (MAPK1) LPAR5 Homo sapiens Lysophosphatidic acid receptor 5 (LPAR5) LAMC3 Homo sapiens Laminin subunit gamma 3 (LAMC3) lpar6 Homo sapiens Lysophosphatidic acid receptor 6 (LPAR6) JUN Homo sapiens Jun proto-oncogene, AP-1 transcription factor subunit (JUN) MAPK3 Homo sapiens Mitogen-activated protein kinase 3 (MAPK3) VEGFA Homo sapiens Vascular endothelial growth factor A (VEGFA) PDGFRA Homo sapiens Platelet derived growth factor receptor alpha (PDGFRA) MAPK9 Homo sapiens Mitogen-activated protein kinase 9 (MAPK9) PDGFRB Homo sapiens Platelet derived growth factor receptor beta (PDGFRB) LAMC2 Homo sapiens Laminin subunit gamma 2 (LAMC2) MAPK8 Homo sapiens Mitogen-activated protein kinase 8 (MAPK8) LAMC1 Homo sapiens Laminin subunit gamma 1 (LAMC1) ITGA2B Homo sapiens Integrin subunit alpha 2b (ITGA2B) gnai3 Homo sapiens G protein subunit alpha i3 (GNAI3) GNAI2 Homo sapiens G protein subunit alpha i2 (GNAI2) NFKBIA Homo sapiens NFKB inhibitor alpha (NFKBIA) BDKRB1 Homo sapiens Bradykinin receptor B1 (BDKRB1) BDKRB2 Homo sapiens Bradykinin receptor B2 (BDKRB2) BCL2L1 Homo sapiens BCL2 like 1 (BCL2L1) LAMB3 Homo sapiens Laminin subunit beta 3 (LAMB3) LAMB2 Homo sapiens Laminin subunit beta 2 (LAMB2) kras Homo sapiens KRAS proto-oncogene, GTPase (KRAS) RAC3 Homo sapiens Ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) (RAC3) RAC1 Homo sapiens Ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) (RAC1) BMP4 Homo sapiens Bone morphogenetic protein 4 (BMP4) DVL3 Homo sapiens Dishevelled segment polarity protein 3 (DVL3) TCF7 Homo sapiens Transcription factor 7 (T-cell specific, HMG-box) (TCF7) BMP2 Homo sapiens Bone morphogenetic protein 2 (BMP2) MAP2K1 Homo sapiens Mitogen-activated protein kinase kinase 1 (MAP2K1) MAP2K2 Homo sapiens Mitogen-activated protein kinase kinase 2 (MAP2K2) TGFBR1 Homo sapiens Transforming growth factor beta receptor 1 (TGFBR1) TGFBR2 Homo sapiens Transforming growth factor beta receptor 2 (TGFBR2) CREBBP Homo sapiens CREB binding protein (CREBBP) SMAD4 Homo sapiens SMAD family member 4 (SMAD4) SMAD3 Homo sapiens SMAD family member 3 (SMAD3) SMAD2 Homo sapiens SMAD family member 2 (SMAD2) HGF Homo sapiens Hepatocyte growth factor (HGF) DVL1 Homo sapiens Dishevelled segment polarity protein 1 (DVL1) CBLB Homo sapiens Cbl proto-oncogene B (CBLB) LAMA5 Homo sapiens Laminin subunit alpha 5 (LAMA5) ETS1 Homo sapiens ETS proto-oncogene 1, transcription factor (ETS1) NTRK1 Homo sapiens Neurotrophic receptor tyrosine kinase 1 (NTRK1) FGF5 Homo sapiens Fibroblast growth factor 5 (FGF5) PPARD Homo sapiens Peroxisome proliferator activated receptor delta (PPARD) FGF8 Homo sapiens Fibroblast growth factor 8 (FGF8) FGF7 Homo sapiens Fibroblast growth factor 7 (FGF7) FGF9 Homo sapiens Fibroblast growth factor 9 (FGF9) PPARG Homo sapiens Peroxisome proliferator activated receptor gamma (PPARG) MITF Homo sapiens Melanogenesis associated transcription factor (MITF) SPI1 Homo sapiens Spi-1 proto-oncogene (SPI1) NFKB1 Homo sapiens Nuclear factor kappa B subunit 1 (NFKB1) NFKB2 Homo sapiens Nuclear factor kappa B subunit 2 (NFKB2) GLI2 Homo sapiens GLI family zinc finger 2 (GLI2) PTEN Homo sapiens Phosphatase and tensin homolog (PTEN) GLI3 Homo sapiens GLI family zinc finger 3 (GLI3) EDNRA Homo sapiens Endothelin receptor type A (EDNRA) EDNRB Homo sapiens Endothelin receptor type B (EDNRB) CCNE1 Homo sapiens Cyclin E1 (CCNE1) TGFA Homo sapiens Transforming growth factor alpha (TGFA) HHIP Homo sapiens Hedgehog interacting protein (HHIP) FGF1 Homo sapiens Fibroblast growth factor 1 (FGF1) FGF2 Homo sapiens Fibroblast growth factor 2 (FGF2) FGF3 Homo sapiens Fibroblast growth factor 3 (FGF3) FGF4 Homo sapiens Fibroblast growth factor 4 (FGF4) ar Homo sapiens Androgen receptor (AR) arhgef1 Homo sapiens Rho guanine nucleotide exchange factor 1 (ARHGEF1) TP53 Homo sapiens Tumor protein p53 (TP53) ARHGEF12 Homo sapiens Rho guanine nucleotide exchange factor 12 (ARHGEF12) CCND1 Homo sapiens Cyclin D1 (CCND1) GNB2 Homo sapiens G protein subunit beta 2 (GNB2) GNAQ Homo sapiens G protein subunit alpha q (GNAQ) GNB1 Homo sapiens G protein subunit beta 1 (GNB1) WNT9B Homo sapiens Wnt family member 9B (WNT9B) GNB5 Homo sapiens G protein subunit beta 5 (GNB5) GNB4 Homo sapiens G protein subunit beta 4 (GNB4) GNAS Homo sapiens GNAS complex locus (GNAS) BID Homo sapiens BH3 interacting domain death agonist (BID) APC2 Homo sapiens APC2, WNT signaling pathway regulator (APC2) PML Homo sapiens promyelocytic leukemia (PML) ZBTB16 Homo sapiens zinc finger and BTB domain containing 16 (ZBTB16) GNG12 Homo sapiens G protein subunit gamma 12 (GNG12) KIT Homo sapiens KIT proto-oncogene receptor tyrosine kinase (KIT) sufu Homo sapiens SUFU negative regulator of hedgehog signaling (SUFU) SOS1 Homo sapiens SOS Ras/Rac guanine nucleotide exchange factor 1 (SOS1) BCL2 Homo sapiens BCL2, apoptosis regulator (BCL2) PLEKHG5 Homo sapiens pleckstrin homology and RhoGEF domain containing G5 (PLEKHG5) WNT8B Homo sapiens Wnt family member 8B (WNT8B) FZD9 Homo sapiens Frizzled class receptor 9 (FZD9) FZD8 Homo sapiens Frizzled class receptor 8 (FZD8) FZD1 Homo sapiens Frizzled class receptor 1 (FZD1) BIRC7 Homo sapiens Baculoviral IAP repeat containing 7 (BIRC7) IGF1 Homo sapiens Insulin like growth factor 1 (IGF1) FZD3 Homo sapiens Frizzled class receptor 3 (FZD3) BIRC5 Homo sapiens Baculoviral IAP repeat containing 5 (BIRC5) MAPK10 Homo sapiens Mitogen-activated protein kinase 10 (MAPK10) FZD2 Homo sapiens Frizzled class receptor 2 (FZD2) FZD5 Homo sapiens Frizzled class receptor 5 (FZD5) APPL1 Homo sapiens Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 (APPL1) BIRC3 Homo sapiens Baculoviral IAP repeat containing 3 (BIRC3) FZD4 Homo sapiens Frizzled class receptor 4 (FZD4) FZD7 Homo sapiens frizzled class receptor 7 (FZD7) STAT3 Homo sapiens signal transducer and activator of transcription 3 (STAT3) NRAS Homo sapiens neuroblastoma RAS viral oncogene homolog (NRAS) WNT7B Homo sapiens Wnt family member 7B (WNT7B) RASSF5 Homo sapiens Ras association domain family member 5 (RASSF5) ADCY9 Homo sapiens Adenylate cyclase 9 (ADCY9) GSK3B Homo sapiens Glycogen synthase kinase 3 beta (GSK3B) GNG10 Homo sapiens G protein subunit gamma 10 (GNG10) ARAF Homo sapiens A-Raf proto-oncogene, serine/threonine kinase (ARAF) TCEB2 Homo sapiens Transcription elongation factor B subunit 2 (TCEB2) PTCH1 Homo sapiens Patched 1 (PTCH1) PTCH2 Homo sapiens Patched 2 (PTCH2) TCEB1 Homo sapiens Transcription elongation factor B subunit 1 (TCEB1) FGF19 Homo sapiens Fibroblast growth factor 19 (FGF19) GNA13 Homo sapiens G protein subunit alpha 13 (GNA13) FGF18 Homo sapiens Fibroblast growth factor 18 (FGF18) F2RL3 Homo sapiens F2R like thrombin/trypsin receptor 3 (F2RL3) PDGFB Homo sapiens Platelet derived growth factor subunit B (PDGFB) PDGFA Homo sapiens Platelet derived growth factor subunit A (PDGFA) FGF14 Homo sapiens Fibroblast growth factor 14 (FGF14) WNT3A Homo sapiens Wnt family member 3A (WNT3A) GNA11 Homo sapiens G protein subunit alpha 11 (GNA11) ARNT2 Homo sapiens Aryl hydrocarbon receptor nuclear translocator 2 (ARNT2) GNA12 Homo sapiens G protein subunit alpha 12 (GNA12) TGFB3 Homo sapiens Transforming growth factor beta 3 (TGFB3) FGF11 Homo sapiens Fibroblast growth factor 11 (FGF11) FOXO3 Homo sapiens Forkhead box O3 (FOXO3)
Load more

Recommended publications
  • Endothelin System and Therapeutic Application of Endothelin Receptor
    xperim ACCESS Freely available online & E en OPEN l ta a l ic P in h l a C r m f o a c l a o n l o r g u y o J Journal of ISSN: 2161-1459 Clinical & Experimental Pharmacology Research Article Endothelin System and Therapeutic Application of Endothelin Receptor Antagonists Abebe Basazn Mekuria, Zemene Demelash Kifle*, Mohammedbrhan Abdelwuhab Department of Pharmacology, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia ABSTRACT Endothelin is a 21 amino acid molecule endogenous potent vasoconstrictor peptide. Endothelin is synthesized in vascular endothelial and smooth muscle cells, as well as in neural, renal, pulmonic, and inflammatory cells. It acts through a seven transmembrane endothelin receptor A (ETA) and endothelin receptor B (ETB) receptors belongs to G protein-coupled rhodopsin-type receptor superfamily. This peptide involved in pathogenesis of cardiovascular disorder like (heart failure, arterial hypertension, myocardial infraction and atherosclerosis), renal failure, pulmonary arterial hypertension and it also involved in pathogenesis of cancer. Potentially endothelin receptor antagonist helps the treatment of the above disorder. Currently, there are a lot of trails both per-clinical and clinical on endothelin antagonist for various cardiovascular, pulmonary and cancer disorder. Some are approved by FAD for the treatment. These agents are including both selective and non-selective endothelin receptor antagonist (ETA/B). Currently, Bosentan, Ambrisentan, and Macitentan approved
    [Show full text]
  • Fog2 Is Critical for Cardiac Function and Maintenance of Coronary Vasculature in the Adult Mouse Heart
    Fog2 is critical for cardiac function and maintenance of coronary vasculature in the adult mouse heart Bin Zhou, … , Sergei G. Tevosian, William T. Pu J Clin Invest. 2009;119(6):1462-1476. https://doi.org/10.1172/JCI38723. Research Article Cardiology Aberrant transcriptional regulation contributes to the pathogenesis of both congenital and adult forms of heart disease. While the transcriptional regulator friend of Gata 2 (FOG2) is known to be essential for heart morphogenesis and coronary development, its tissue-specific function has not been previously investigated. Additionally, little is known about the role of FOG2 in the adult heart. Here we used spatiotemporally regulated inactivation of Fog2 to delineate its function in both the embryonic and adult mouse heart. Early cardiomyocyte-restricted loss of Fog2 recapitulated the cardiac and coronary defects of the Fog2 germline murine knockouts. Later cardiomyocyte-restricted loss ofF og2 (Fog2MC) did not result in defects in cardiac structure or coronary vessel formation. However, Fog2MC adult mice had severely depressed ventricular function and died at 8–14 weeks. Fog2MC adult hearts displayed a paucity of coronary vessels, associated with myocardial hypoxia, increased cardiomyocyte apoptosis, and cardiac fibrosis. Induced inactivation of Fog2 in the adult mouse heart resulted in similar phenotypes, as did ablation of the FOG2 interaction with the transcription factor GATA4. Loss of the FOG2 or FOG2-GATA4 interaction altered the expression of a panel of angiogenesis-related genes. Collectively, our data indicate that FOG2 regulates adult heart function and coronary angiogenesis. Find the latest version: https://jci.me/38723/pdf Research article Fog2 is critical for cardiac function and maintenance of coronary vasculature in the adult mouse heart Bin Zhou,1,2 Qing Ma,1 Sek Won Kong,1 Yongwu Hu,1,3 Patrick H.
    [Show full text]
  • F2RL2 Antibody Cat
    F2RL2 Antibody Cat. No.: 56-323 F2RL2 Antibody F2RL2 Antibody immunohistochemistry analysis in formalin fixed and paraffin embedded human heart tissue followed by peroxidase conjugation of the secondary antibody and DAB staining. Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Human This F2RL2 antibody is generated from rabbits immunized with a KLH conjugated IMMUNOGEN: synthetic peptide between 21-50 amino acids from the N-terminal region of human F2RL2. TESTED APPLICATIONS: IHC-P, WB For WB starting dilution is: 1:1000 APPLICATIONS: For IHC-P starting dilution is: 1:10~50 PREDICTED MOLECULAR 43 kDa WEIGHT: September 25, 2021 1 https://www.prosci-inc.com/f2rl2-antibody-56-323.html Properties This antibody is purified through a protein A column, followed by peptide affinity PURIFICATION: purification. CLONALITY: Polyclonal ISOTYPE: Rabbit Ig CONJUGATE: Unconjugated PHYSICAL STATE: Liquid BUFFER: Supplied in PBS with 0.09% (W/V) sodium azide. CONCENTRATION: batch dependent Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies STORAGE CONDITIONS: care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures. Additional Info OFFICIAL SYMBOL: F2RL2 Proteinase-activated receptor 3, PAR-3, Coagulation factor II receptor-like 2, Thrombin ALTERNATE NAMES: receptor-like 2, F2RL2, PAR3 ACCESSION NO.: O00254 GENE ID: 2151 USER NOTE: Optimal dilutions for each application to be determined by the researcher. Background and References Coagulation factor II (thrombin) receptor-like 2 (F2RL2) is a member of the large family of 7-transmembrane-region receptors that couple to guanosine-nucleotide-binding proteins.
    [Show full text]
  • Lysophosphatidic Acid and Its Receptors: Pharmacology and Therapeutic Potential in Atherosclerosis and Vascular Disease
    JPT-107404; No of Pages 13 Pharmacology & Therapeutics xxx (2019) xxx Contents lists available at ScienceDirect Pharmacology & Therapeutics journal homepage: www.elsevier.com/locate/pharmthera Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease Ying Zhou a, Peter J. Little a,b, Hang T. Ta a,c, Suowen Xu d, Danielle Kamato a,b,⁎ a School of Pharmacy, University of Queensland, Pharmacy Australia Centre of Excellence, Woolloongabba, QLD 4102, Australia b Department of Pharmacy, Xinhua College of Sun Yat-sen University, Tianhe District, Guangzhou 510520, China c Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, St Lucia, QLD 4072, Australia d Aab Cardiovascular Research Institute, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA article info abstract Available online xxxx Lysophosphatidic acid (LPA) is a collective name for a set of bioactive lipid species. Via six widely distributed G protein-coupled receptors (GPCRs), LPA elicits a plethora of biological responses, contributing to inflammation, Keywords: thrombosis and atherosclerosis. There have recently been considerable advances in GPCR signaling especially Lysophosphatidic acid recognition of the extended role for GPCR transactivation of tyrosine and serine/threonine kinase growth factor G-protein coupled receptors receptors. This review covers LPA signaling pathways in the light of new information. The use of transgenic and Atherosclerosis gene knockout animals, gene manipulated cells, pharmacological LPA receptor agonists and antagonists have Gproteins fi β-arrestins provided many insights into the biological signi cance of LPA and individual LPA receptors in the progression Transactivation of atherosclerosis and vascular diseases.
    [Show full text]
  • ARTICLES Fibroblast Growth Factors 1, 2, 17, and 19 Are The
    0031-3998/07/6103-0267 PEDIATRIC RESEARCH Vol. 61, No. 3, 2007 Copyright © 2007 International Pediatric Research Foundation, Inc. Printed in U.S.A. ARTICLES Fibroblast Growth Factors 1, 2, 17, and 19 Are the Predominant FGF Ligands Expressed in Human Fetal Growth Plate Cartilage PAVEL KREJCI, DEBORAH KRAKOW, PERTCHOUI B. MEKIKIAN, AND WILLIAM R. WILCOX Medical Genetics Institute [P.K., D.K., P.B.M., W.R.W.], Cedars-Sinai Medical Center, Los Angeles, California 90048; Department of Obstetrics and Gynecology [D.K.] and Department of Pediatrics [W.R.W.], UCLA School of Medicine, Los Angeles, California 90095 ABSTRACT: Fibroblast growth factors (FGF) regulate bone growth, (G380R) or TD (K650E) mutations (4–6). When expressed at but their expression in human cartilage is unclear. Here, we deter- physiologic levels, FGFR3-G380R required, like its wild-type mined the expression of entire FGF family in human fetal growth counterpart, ligand for activation (7). Similarly, in vitro cul- plate cartilage. Using reverse transcriptase PCR, the transcripts for tivated human TD chondrocytes as well as chondrocytes FGF1, 2, 5, 8–14, 16–19, and 21 were found. However, only FGF1, isolated from Fgfr3-K644M mice had an identical time course 2, 17, and 19 were detectable at the protein level. By immunohisto- of Fgfr3 activation compared with wild-type chondrocytes and chemistry, FGF17 and 19 were uniformly expressed within the showed no receptor activation in the absence of ligand (8,9). growth plate. In contrast, FGF1 was found only in proliferating and hypertrophic chondrocytes whereas FGF2 localized predominantly to Despite the importance of the FGF ligand for activation of the resting and proliferating cartilage.
    [Show full text]
  • Disruption of Fibroblast Growth Factor Signal
    Cancer Therapy: Preclinical Disruption of Fibroblast Growth Factor Signal Pathway Inhibits the Growth of Synovial Sarcomas: Potential Application of Signal Inhibitors to MolecularTarget Therapy Ta t s u y a I s hi b e , 1, 2 Tomitaka Nakayama,2 Ta k e s h i O k a m o t o, 1, 2 Tomoki Aoyama,1Koichi Nishijo,1, 2 Kotaro Roberts Shibata,1, 2 Ya s u ko Shim a ,1, 2 Satoshi Nagayama,3 Toyomasa Katagiri,4 Yusuke Nakamura, 4 Takashi Nakamura,2 andJunya Toguchida 1 Abstract Purpose: Synovial sarcoma is a soft tissue sarcoma, the growth regulatory mechanisms of which are unknown.We investigatedthe involvement of fibroblast growth factor (FGF) signals in synovial sarcoma andevaluatedthe therapeutic effect of inhibiting the FGF signal. Experimental Design:The expression of 22 FGF and4 FGF receptor (FGFR) genes in18prima- ry tumors andfive cell lines of synovial sarcoma were analyzedby reverse transcription-PCR. Effects of recombinant FGF2, FGF8, andFGF18 for the activation of mitogen-activatedprotein kinase (MAPK) andthe growth of synovial sarcoma cell lines were analyzed.Growth inhibitory effects of FGFR inhibitors on synovial sarcoma cell lines were investigated in vitro and in vivo. Results: Synovial sarcoma cell lines expressedmultiple FGF genes especially those expressed in neural tissues, among which FGF8 showedgrowth stimulatory effects in all synovial sarcoma cell lines. FGF signals in synovial sarcoma induced the phosphorylation of extracellular signal ^ regulatedkinase (ERK1/2) andp38MAPK but not c-Jun NH 2-terminal kinase. Disruption of the FGF signaling pathway in synovial sarcoma by specific inhibitors of FGFR causedcell cycle ar- rest leading to significant growth inhibition both in vitro and in vivo.Growthinhibitionbythe FGFR inhibitor was associatedwith a down-regulation of phosphorylatedERK1/2 but not p38MAPK, andan ERK kinase inhibitor also showedgrowth inhibitory effects for synovial sar- coma, indicating that the growth stimulatory effect of FGF was transmitted through the ERK1/2.
    [Show full text]
  • FGF14 Regulates Presynaptic Ca2+ Channels and Synaptic Transmission
    Cell Reports Article FGF14 Regulates Presynaptic Ca2+ Channels and Synaptic Transmission Haidun Yan,1,3 Juan L. Pablo,2,3 and Geoffrey S. Pitt1,2,3,* 1Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA 2Department of Neurobiology, Duke University Medical Center, Durham, NC 27710, USA 3Ion Channel Research Unit, Duke University Medical Center, Durham, NC 27710, USA *Correspondence: [email protected] http://dx.doi.org/10.1016/j.celrep.2013.06.012 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited. SUMMARY data pinpointed FGF14 as the locus for spinocerebellar ataxia 27 (SCA27). Fibroblast growth factor homologous factors (FHFs) Focus on FHF regulation of neuronal excitability began when are not growth factors, but instead bind to voltage- Fgf14–/– mice showed ataxia (Wang et al., 2002), providing + gated Na channels (NaV) and regulate their function. a basis for exploring the implications of a linkage analysis that Mutations in FGF14, an FHF that is the locus for identified a F150S missense mutation in a ‘‘b’’ splice variant of F150S F145S spinocerebellar ataxia 27 (SCA27), are believed to FGF14 (FGF14b ; termed FGF14 in some studies that be pathogenic because of a dominant-negative used numbering based on the alternatively spliced FGF14a variant) as the etiology of the autosomal-dominant SCA27 in reduction of Na currents in cerebellar granule cells. V an extended Dutch family (van Swieten et al., 2003).
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Supplementary Table 3 Complete List of RNA-Sequencing Analysis of Gene Expression Changed by ≥ Tenfold Between Xenograft and Cells Cultured in 10%O2
    Supplementary Table 3 Complete list of RNA-Sequencing analysis of gene expression changed by ≥ tenfold between xenograft and cells cultured in 10%O2 Expr Log2 Ratio Symbol Entrez Gene Name (culture/xenograft) -7.182 PGM5 phosphoglucomutase 5 -6.883 GPBAR1 G protein-coupled bile acid receptor 1 -6.683 CPVL carboxypeptidase, vitellogenic like -6.398 MTMR9LP myotubularin related protein 9-like, pseudogene -6.131 SCN7A sodium voltage-gated channel alpha subunit 7 -6.115 POPDC2 popeye domain containing 2 -6.014 LGI1 leucine rich glioma inactivated 1 -5.86 SCN1A sodium voltage-gated channel alpha subunit 1 -5.713 C6 complement C6 -5.365 ANGPTL1 angiopoietin like 1 -5.327 TNN tenascin N -5.228 DHRS2 dehydrogenase/reductase 2 leucine rich repeat and fibronectin type III domain -5.115 LRFN2 containing 2 -5.076 FOXO6 forkhead box O6 -5.035 ETNPPL ethanolamine-phosphate phospho-lyase -4.993 MYO15A myosin XVA -4.972 IGF1 insulin like growth factor 1 -4.956 DLG2 discs large MAGUK scaffold protein 2 -4.86 SCML4 sex comb on midleg like 4 (Drosophila) Src homology 2 domain containing transforming -4.816 SHD protein D -4.764 PLP1 proteolipid protein 1 -4.764 TSPAN32 tetraspanin 32 -4.713 N4BP3 NEDD4 binding protein 3 -4.705 MYOC myocilin -4.646 CLEC3B C-type lectin domain family 3 member B -4.646 C7 complement C7 -4.62 TGM2 transglutaminase 2 -4.562 COL9A1 collagen type IX alpha 1 chain -4.55 SOSTDC1 sclerostin domain containing 1 -4.55 OGN osteoglycin -4.505 DAPL1 death associated protein like 1 -4.491 C10orf105 chromosome 10 open reading frame 105 -4.491
    [Show full text]
  • Bradykinin Receptor Deficiency Or Antagonism Do Not Impact the Host
    Ding et al. Intensive Care Medicine Experimental (2019) 7:14 Intensive Care Medicine https://doi.org/10.1186/s40635-019-0228-3 Experimental RESEARCH Open Access Bradykinin receptor deficiency or antagonism do not impact the host response during gram-negative pneumonia-derived sepsis Chao Ding1,2, Jack Yang2, Cornelis van’t Veer2 and Tom van der Poll2,3* * Correspondence: t.vanderpoll@ amc.uva.nl Abstract 2Center of Experimental and Molecular Medicine, Academic Background: Kinins are short peptides with a wide range of proinflammatory Medical Center, University of properties that are generated from kininogens in the so-called kallikrein-kinin system. Amsterdam, Meibergdreef 9, Room Kinins exert their biological activities through stimulation of two distinct receptor G2-130, 1105 AZ Amsterdam, the Netherlands subtypes, the kinin or bradykinin B1 and B2 receptors (B1R, B2R). Acute challenge 3Division of Infectious Diseases, models have implicated B1R and B2R in the pathogenesis of sepsis. However, their Academic Medical Center, role in the host response during sepsis originating from the lung is not known. University of Amsterdam, Amsterdam, the Netherlands Results: To determine the role of B1R and B2R in pneumonia-derived sepsis, B1R/ Full list of author information is B2R-deficient mice and wild-type mice treated with the B1R antagonist R-715 or the available at the end of the article B2R antagonist HOE-140 were studied after infection with the common gram- negative pathogen Klebsiella pneumoniae via the airways. Neither B1R/B2R deficiency nor B1R or B2R inhibition influenced bacterial growth at the primary site of infection or dissemination to distant body sites.
    [Show full text]
  • An Explanation of G-Protein Coupled Receptor Structure
    Journal of Stem Cell Research & Therapeutics Review Article Open Access Role of GPCRS towards cell: an explanation of g-protein coupled receptor structure Abstract Volume 2 Issue 3 - 2017 G- protein coupled receptors are the heptahelical, serpentine receptor and are Nidhi Sharma,1 Anil Kumar Sahdev,2 Vinit Raj2 multifunctional receptors having modulatory activity of a wide variety of biological 1Dr. K. N. Modi Institute of Pharmacy & Research centre, process including: Neurotransmission, Chemoattraction, Cardiac function, Olfaction Modinagar, India. and Vision etc. At largest level they are involved in signal transduction across cell 2Department of Pharmaceutical Sciences, Babasaheb Bhimrao membranes therefore they represent major targets in the development of novel drug Ambedkar University, India candidates in all clinical areas. Particularly membrane cholesterol has been reported to have a great role in the functioning of a number of GPCRs. Apart from this it also Correspondence: Vinit Raj, Department of Pharmaceutical have some drawbacks. Mutations that occur are associated with a broad spectrum of Sciences, Babasaheb Bhimrao Ambedkar University, VidyaVihar, diseases of diverse etiology. As a mutations result, there is a change in receptor activity Rae Bareli Road, Lucknow-226025, Email [email protected] (GPCR become inactive, overactive, or constitutively active), in the process of ligand binding and signal transduction. Changes in the GPCRs functioning can cause diseases Received: January 31, 2017 | Published: March 27, 2017 such as retinitis pigmentosa (rhodopsin mutations), nephrogenic diabetes insipidus (vasopressin receptor mutations), and obesity (melanocortin receptor mutations). Keywords: gpcrs, serpentine receptor, neurotransmission, retinitis pigmentosa, nephrogenic diabetes insipidus, bardet-biedl syndrome, hypogonadism Introduction deliver a message and appropriate cellular and physiological response1,2 (Figure 1).
    [Show full text]
  • Instability Restricts Signaling of Multiple Fibroblast Growth Factors
    Cell. Mol. Life Sci. DOI 10.1007/s00018-015-1856-8 Cellular and Molecular Life Sciences RESEARCH ARTICLE Instability restricts signaling of multiple fibroblast growth factors Marcela Buchtova • Radka Chaloupkova • Malgorzata Zakrzewska • Iva Vesela • Petra Cela • Jana Barathova • Iva Gudernova • Renata Zajickova • Lukas Trantirek • Jorge Martin • Michal Kostas • Jacek Otlewski • Jiri Damborsky • Alois Kozubik • Antoni Wiedlocha • Pavel Krejci Received: 18 June 2014 / Revised: 7 February 2015 / Accepted: 9 February 2015 Ó Springer Basel 2015 Abstract Fibroblast growth factors (FGFs) deliver ex- failure to activate FGF receptor signal transduction over tracellular signals that govern many developmental and long periods of time, and influence specific cell behavior regenerative processes, but the mechanisms regulating FGF in vitro and in vivo. Stabilization via exogenous heparin signaling remain incompletely understood. Here, we ex- binding, introduction of stabilizing mutations or lowering plored the relationship between intrinsic stability of FGF the cell cultivation temperature rescues signaling of un- proteins and their biological activity for all 18 members of stable FGFs. Thus, the intrinsic ligand instability is an the FGF family. We report that FGF1, FGF3, FGF4, FGF6, important elementary level of regulation in the FGF sig- FGF8, FGF9, FGF10, FGF16, FGF17, FGF18, FGF20, and naling system. FGF22 exist as unstable proteins, which are rapidly de- graded in cell cultivation media. Biological activity of Keywords Fibroblast growth factor Á FGF Á Unstable Á FGF1, FGF3, FGF4, FGF6, FGF8, FGF10, FGF16, FGF17, Proteoglycan Á Regulation and FGF20 is limited by their instability, manifesting as Electronic supplementary material The online version of this article (doi:10.1007/s00018-015-1856-8) contains supplementary material, which is available to authorized users.
    [Show full text]